Position in NBIX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$37,156,833
+$10,329,696 QoQ
Shares Held
220,463
+8.3% QoQ
Ownership
0.217%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#77
of 768 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Amundi holds $594,123,116 across 28 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,988,618 | $286,622,087 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
219,094 | $118,711,701 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,929,853 | $65,383,418 | |
| 4 | VTRS |
Viatris Inc
|
3,269,550 | $51,920,453 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
This page
|
220,463 | $37,156,833 | |
| 6 | ALKS |
Alkermes plc.
|
217,739 | $11,409,523 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
82,089 | $9,106,952 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
31,793 | $2,631,824 |
All Filings in NBIX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $37,156,833 | 220,463 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $26,827,137 | 203,637 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $23,593,419 | 166,350 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $32,324,319 | 230,263 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $27,550,618 | 219,195 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $25,569,280 | 231,187 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $35,743,889 | 261,860 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $75,664,394 | 656,695 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $53,872,056 | 391,313 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $49,881,800 | 361,672 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $44,826,594 | 340,214 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $34,356,823 | 305,394 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $112,219,448 | 1,190,026 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $123,674,742 | 1,221,841 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $110,286,831 | 923,366 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $86,753,600 | 816,812 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,362,517 | 65,270 | Shares | Defined | 2022-09-02 | |
| 2022-03-31 | $6,173,527 | 65,851 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $11,874,564 | 139,422 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $13,225,507 | 137,895 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $11,852,206 | 121,786 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||